Traitement tocolytique prénatal et durée d’allaitement
Etude sur le lien entre la prise de traitement tocolytique et la durée de l’allaitement ou l’hypogalactie.
Résumé de l’auteur :
« Background: To date there are no clinical studies analyzing potential effects of tocolytics on breastfeeding duration in humans.
Objectives: The purpose of this study was to evaluate the association between beta 2 agonists prescribed for tocolysis during pregnancy and breastfeeding duration.
Results: There was a statistically significant difference between breastfeeding duration of mothers who were on tocolytics during pregnancy versus those who were not prescribed tocolytics (9.5 ± 5.7 months versus 4.5 ± 2.1 months) p < 0.001. In addition, hypogalactia was statistically significantly more prevalent in mothers with positive history versus mothers with negative history of tocolytic usage p < 0.001.
Conclusion: The results of our study indicate that tocolytic treatment in pregnancy is associated with shorter breastfeeding duration and hypogalactia. »
Bjelakovic Ljiljana, Trajkovic Tatjana, Kocic Gordana. The Association of Prenatal Tocolysis and Breastfeeding Duration. Breastfeeding Medicine. December 2016, 11(10): 561-563. doi:10.1089/bfm.2016.0130.